0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Endocrine Therapy Medication Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-11Z18384
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Endocrine Therapy Medication Market Research Report 2024
BUY CHAPTERS

Global Endocrine Therapy Medication Market Research Report 2024

Code: QYRE-Auto-11Z18384
Report
September 2024
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Endocrine Therapy Medication Market

Endocrine therapy drugs are a class of drugs used to treat hormone-related diseases, mainly by regulating the level of hormones in the body or blocking the effects of hormones to achieve therapeutic effects. This type of drug is widely used to treat certain types of cancer (such as breast cancer and prostate cancer), thyroid diseases, diabetes, osteoporosis and other endocrine system diseases.
The global Endocrine Therapy Medication market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Endocrine Therapy Medication is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Endocrine Therapy Medication is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Endocrine Therapy Medication include Maanshan Fengyuan Pharmaceutical Co., Ltd., Shanghai Lizhu Pharmaceutical Co., Ltd., Zhongpeptide Biochemical Co., Ltd., Beijing Bornte Pharmaceutical Co., Ltd., Chengdu Tiantaishan Pharmaceutical Co., Ltd., Shenzhen Hanyu Pharmaceutical Co., Ltd., Chongqing Laimi Pharmaceutical Co., Ltd., Changchun Jinsai Pharmaceutical Co., Ltd., Dandong Yichuang Pharmaceutical Co., Ltd., Good Doctor Pharmaceutical Group Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Endocrine Therapy Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrine Therapy Medication.
The Endocrine Therapy Medication market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Endocrine Therapy Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocrine Therapy Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Endocrine Therapy Medication Market Report

Report Metric Details
Report Name Endocrine Therapy Medication Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Maanshan Fengyuan Pharmaceutical Co., Ltd., Shanghai Lizhu Pharmaceutical Co., Ltd., Zhongpeptide Biochemical Co., Ltd., Beijing Bornte Pharmaceutical Co., Ltd., Chengdu Tiantaishan Pharmaceutical Co., Ltd., Shenzhen Hanyu Pharmaceutical Co., Ltd., Chongqing Laimi Pharmaceutical Co., Ltd., Changchun Jinsai Pharmaceutical Co., Ltd., Dandong Yichuang Pharmaceutical Co., Ltd., Good Doctor Pharmaceutical Group Co., Ltd., Yangtze River Pharmaceutical Group Co., Ltd., Zhejiang Haizhou Pharmaceutical Co., Ltd., Zhejiang Haizheng Pharmaceutical Co., Ltd., Shanghai Zhaohui Pharmaceutical Co., Ltd., Jiangsu Tasly Diyi Pharmaceutical Co., Ltd., Shanghai Fudan Fuhua Pharmaceutical Co., Ltd., Jiangsu Aosaikang Pharmaceutical Co., Ltd., Eli Lilly and Company, Pfizer, Teva, AstraZeneca, Janssen Biotech, Dr. Reddy's, Cougar Biotechnology, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Endocrine Therapy Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Endocrine Therapy Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Endocrine Therapy Medication Market report?

Ans: The main players in the Endocrine Therapy Medication Market are Maanshan Fengyuan Pharmaceutical Co., Ltd., Shanghai Lizhu Pharmaceutical Co., Ltd., Zhongpeptide Biochemical Co., Ltd., Beijing Bornte Pharmaceutical Co., Ltd., Chengdu Tiantaishan Pharmaceutical Co., Ltd., Shenzhen Hanyu Pharmaceutical Co., Ltd., Chongqing Laimi Pharmaceutical Co., Ltd., Changchun Jinsai Pharmaceutical Co., Ltd., Dandong Yichuang Pharmaceutical Co., Ltd., Good Doctor Pharmaceutical Group Co., Ltd., Yangtze River Pharmaceutical Group Co., Ltd., Zhejiang Haizhou Pharmaceutical Co., Ltd., Zhejiang Haizheng Pharmaceutical Co., Ltd., Shanghai Zhaohui Pharmaceutical Co., Ltd., Jiangsu Tasly Diyi Pharmaceutical Co., Ltd., Shanghai Fudan Fuhua Pharmaceutical Co., Ltd., Jiangsu Aosaikang Pharmaceutical Co., Ltd., Eli Lilly and Company, Pfizer, Teva, AstraZeneca, Janssen Biotech, Dr. Reddy's, Cougar Biotechnology, Inc.

What are the Application segmentation covered in the Endocrine Therapy Medication Market report?

Ans: The Applications covered in the Endocrine Therapy Medication Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Endocrine Therapy Medication Market report?

Ans: The Types covered in the Endocrine Therapy Medication Market report are Hormones and Related Drugs, Hormone Antagonists and Related Drugs

Recommended Reports

Hormonal Drugs Markets

Cancer Therapy Markets

Therapy Devices Markets

1 Endocrine Therapy Medication Market Overview
1.1 Product Definition
1.2 Endocrine Therapy Medication by Type
1.2.1 Global Endocrine Therapy Medication Market Value Comparison by Type (2024-2030)
1.2.2 Hormones and Related Drugs
1.2.3 Hormone Antagonists and Related Drugs
1.3 Endocrine Therapy Medication by Application
1.3.1 Global Endocrine Therapy Medication Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Endocrine Therapy Medication Market Size Estimates and Forecasts
1.4.1 Global Endocrine Therapy Medication Revenue 2019-2030
1.4.2 Global Endocrine Therapy Medication Sales 2019-2030
1.4.3 Global Endocrine Therapy Medication Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Endocrine Therapy Medication Market Competition by Manufacturers
2.1 Global Endocrine Therapy Medication Sales Market Share by Manufacturers (2019-2024)
2.2 Global Endocrine Therapy Medication Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Endocrine Therapy Medication Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Endocrine Therapy Medication, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Endocrine Therapy Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Endocrine Therapy Medication, Product Type & Application
2.7 Global Key Manufacturers of Endocrine Therapy Medication, Date of Enter into This Industry
2.8 Global Endocrine Therapy Medication Market Competitive Situation and Trends
2.8.1 Global Endocrine Therapy Medication Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Endocrine Therapy Medication Players Market Share by Revenue
2.8.3 Global Endocrine Therapy Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Endocrine Therapy Medication Market Scenario by Region
3.1 Global Endocrine Therapy Medication Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Endocrine Therapy Medication Sales by Region: 2019-2030
3.2.1 Global Endocrine Therapy Medication Sales by Region: 2019-2024
3.2.2 Global Endocrine Therapy Medication Sales by Region: 2025-2030
3.3 Global Endocrine Therapy Medication Revenue by Region: 2019-2030
3.3.1 Global Endocrine Therapy Medication Revenue by Region: 2019-2024
3.3.2 Global Endocrine Therapy Medication Revenue by Region: 2025-2030
3.4 North America Endocrine Therapy Medication Market Facts & Figures by Country
3.4.1 North America Endocrine Therapy Medication Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Endocrine Therapy Medication Sales by Country (2019-2030)
3.4.3 North America Endocrine Therapy Medication Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Endocrine Therapy Medication Market Facts & Figures by Country
3.5.1 Europe Endocrine Therapy Medication Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Endocrine Therapy Medication Sales by Country (2019-2030)
3.5.3 Europe Endocrine Therapy Medication Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Endocrine Therapy Medication Market Facts & Figures by Region
3.6.1 Asia Pacific Endocrine Therapy Medication Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Endocrine Therapy Medication Sales by Region (2019-2030)
3.6.3 Asia Pacific Endocrine Therapy Medication Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Endocrine Therapy Medication Market Facts & Figures by Country
3.7.1 Latin America Endocrine Therapy Medication Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Endocrine Therapy Medication Sales by Country (2019-2030)
3.7.3 Latin America Endocrine Therapy Medication Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Endocrine Therapy Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Endocrine Therapy Medication Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Endocrine Therapy Medication Sales by Country (2019-2030)
3.8.3 Middle East and Africa Endocrine Therapy Medication Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Endocrine Therapy Medication Sales by Type (2019-2030)
4.1.1 Global Endocrine Therapy Medication Sales by Type (2019-2024)
4.1.2 Global Endocrine Therapy Medication Sales by Type (2025-2030)
4.1.3 Global Endocrine Therapy Medication Sales Market Share by Type (2019-2030)
4.2 Global Endocrine Therapy Medication Revenue by Type (2019-2030)
4.2.1 Global Endocrine Therapy Medication Revenue by Type (2019-2024)
4.2.2 Global Endocrine Therapy Medication Revenue by Type (2025-2030)
4.2.3 Global Endocrine Therapy Medication Revenue Market Share by Type (2019-2030)
4.3 Global Endocrine Therapy Medication Price by Type (2019-2030)
5 Segment by Application
5.1 Global Endocrine Therapy Medication Sales by Application (2019-2030)
5.1.1 Global Endocrine Therapy Medication Sales by Application (2019-2024)
5.1.2 Global Endocrine Therapy Medication Sales by Application (2025-2030)
5.1.3 Global Endocrine Therapy Medication Sales Market Share by Application (2019-2030)
5.2 Global Endocrine Therapy Medication Revenue by Application (2019-2030)
5.2.1 Global Endocrine Therapy Medication Revenue by Application (2019-2024)
5.2.2 Global Endocrine Therapy Medication Revenue by Application (2025-2030)
5.2.3 Global Endocrine Therapy Medication Revenue Market Share by Application (2019-2030)
5.3 Global Endocrine Therapy Medication Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Maanshan Fengyuan Pharmaceutical Co., Ltd.
6.1.1 Maanshan Fengyuan Pharmaceutical Co., Ltd. Company Information
6.1.2 Maanshan Fengyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.1.5 Maanshan Fengyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Shanghai Lizhu Pharmaceutical Co., Ltd.
6.2.1 Shanghai Lizhu Pharmaceutical Co., Ltd. Company Information
6.2.2 Shanghai Lizhu Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.2.5 Shanghai Lizhu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Zhongpeptide Biochemical Co., Ltd.
6.3.1 Zhongpeptide Biochemical Co., Ltd. Company Information
6.3.2 Zhongpeptide Biochemical Co., Ltd. Description and Business Overview
6.3.3 Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.3.5 Zhongpeptide Biochemical Co., Ltd. Recent Developments/Updates
6.4 Beijing Bornte Pharmaceutical Co., Ltd.
6.4.1 Beijing Bornte Pharmaceutical Co., Ltd. Company Information
6.4.2 Beijing Bornte Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.4.5 Beijing Bornte Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Chengdu Tiantaishan Pharmaceutical Co., Ltd.
6.5.1 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information
6.5.2 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.5.5 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Shenzhen Hanyu Pharmaceutical Co., Ltd.
6.6.1 Shenzhen Hanyu Pharmaceutical Co., Ltd. Company Information
6.6.2 Shenzhen Hanyu Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.6.5 Shenzhen Hanyu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Chongqing Laimi Pharmaceutical Co., Ltd.
6.7.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
6.7.2 Chongqing Laimi Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.7.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Changchun Jinsai Pharmaceutical Co., Ltd.
6.8.1 Changchun Jinsai Pharmaceutical Co., Ltd. Company Information
6.8.2 Changchun Jinsai Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.8.5 Changchun Jinsai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Dandong Yichuang Pharmaceutical Co., Ltd.
6.9.1 Dandong Yichuang Pharmaceutical Co., Ltd. Company Information
6.9.2 Dandong Yichuang Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.9.5 Dandong Yichuang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Good Doctor Pharmaceutical Group Co., Ltd.
6.10.1 Good Doctor Pharmaceutical Group Co., Ltd. Company Information
6.10.2 Good Doctor Pharmaceutical Group Co., Ltd. Description and Business Overview
6.10.3 Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.10.5 Good Doctor Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.11 Yangtze River Pharmaceutical Group Co., Ltd.
6.11.1 Yangtze River Pharmaceutical Group Co., Ltd. Company Information
6.11.2 Yangtze River Pharmaceutical Group Co., Ltd. Description and Business Overview
6.11.3 Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.11.5 Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.12 Zhejiang Haizhou Pharmaceutical Co., Ltd.
6.12.1 Zhejiang Haizhou Pharmaceutical Co., Ltd. Company Information
6.12.2 Zhejiang Haizhou Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.12.5 Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Zhejiang Haizheng Pharmaceutical Co., Ltd.
6.13.1 Zhejiang Haizheng Pharmaceutical Co., Ltd. Company Information
6.13.2 Zhejiang Haizheng Pharmaceutical Co., Ltd. Description and Business Overview
6.13.3 Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.13.5 Zhejiang Haizheng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Shanghai Zhaohui Pharmaceutical Co., Ltd.
6.14.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
6.14.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.14.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
6.15.1 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
6.15.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Description and Business Overview
6.15.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.15.5 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
6.16.1 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Company Information
6.16.2 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Description and Business Overview
6.16.3 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.16.5 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Jiangsu Aosaikang Pharmaceutical Co., Ltd.
6.17.1 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information
6.17.2 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Description and Business Overview
6.17.3 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
6.17.5 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.18 Eli Lilly and Company
6.18.1 Eli Lilly and Company Company Information
6.18.2 Eli Lilly and Company Description and Business Overview
6.18.3 Eli Lilly and Company Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Eli Lilly and Company Endocrine Therapy Medication Product Portfolio
6.18.5 Eli Lilly and Company Recent Developments/Updates
6.19 Pfizer
6.19.1 Pfizer Company Information
6.19.2 Pfizer Description and Business Overview
6.19.3 Pfizer Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Pfizer Endocrine Therapy Medication Product Portfolio
6.19.5 Pfizer Recent Developments/Updates
6.20 Teva
6.20.1 Teva Company Information
6.20.2 Teva Description and Business Overview
6.20.3 Teva Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Teva Endocrine Therapy Medication Product Portfolio
6.20.5 Teva Recent Developments/Updates
6.21 AstraZeneca
6.21.1 AstraZeneca Company Information
6.21.2 AstraZeneca Description and Business Overview
6.21.3 AstraZeneca Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.21.4 AstraZeneca Endocrine Therapy Medication Product Portfolio
6.21.5 AstraZeneca Recent Developments/Updates
6.22 Janssen Biotech
6.22.1 Janssen Biotech Company Information
6.22.2 Janssen Biotech Description and Business Overview
6.22.3 Janssen Biotech Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Janssen Biotech Endocrine Therapy Medication Product Portfolio
6.22.5 Janssen Biotech Recent Developments/Updates
6.23 Dr. Reddy's
6.23.1 Dr. Reddy's Company Information
6.23.2 Dr. Reddy's Description and Business Overview
6.23.3 Dr. Reddy's Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Dr. Reddy's Endocrine Therapy Medication Product Portfolio
6.23.5 Dr. Reddy's Recent Developments/Updates
6.24 Cougar Biotechnology, Inc.
6.24.1 Cougar Biotechnology, Inc. Company Information
6.24.2 Cougar Biotechnology, Inc. Description and Business Overview
6.24.3 Cougar Biotechnology, Inc. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Cougar Biotechnology, Inc. Endocrine Therapy Medication Product Portfolio
6.24.5 Cougar Biotechnology, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Endocrine Therapy Medication Industry Chain Analysis
7.2 Endocrine Therapy Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Endocrine Therapy Medication Production Mode & Process
7.4 Endocrine Therapy Medication Sales and Marketing
7.4.1 Endocrine Therapy Medication Sales Channels
7.4.2 Endocrine Therapy Medication Distributors
7.5 Endocrine Therapy Medication Customers
8 Endocrine Therapy Medication Market Dynamics
8.1 Endocrine Therapy Medication Industry Trends
8.2 Endocrine Therapy Medication Market Drivers
8.3 Endocrine Therapy Medication Market Challenges
8.4 Endocrine Therapy Medication Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Endocrine Therapy Medication Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Endocrine Therapy Medication Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Endocrine Therapy Medication Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Endocrine Therapy Medication Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Endocrine Therapy Medication Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Endocrine Therapy Medication Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Endocrine Therapy Medication Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Endocrine Therapy Medication Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Endocrine Therapy Medication, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Endocrine Therapy Medication, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Endocrine Therapy Medication, Product Type & Application
 Table 12. Global Key Manufacturers of Endocrine Therapy Medication, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Endocrine Therapy Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Therapy Medication as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Endocrine Therapy Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Endocrine Therapy Medication Sales by Region (2019-2024) & (K Units)
 Table 18. Global Endocrine Therapy Medication Sales Market Share by Region (2019-2024)
 Table 19. Global Endocrine Therapy Medication Sales by Region (2025-2030) & (K Units)
 Table 20. Global Endocrine Therapy Medication Sales Market Share by Region (2025-2030)
 Table 21. Global Endocrine Therapy Medication Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Endocrine Therapy Medication Revenue Market Share by Region (2019-2024)
 Table 23. Global Endocrine Therapy Medication Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Endocrine Therapy Medication Revenue Market Share by Region (2025-2030)
 Table 25. North America Endocrine Therapy Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Endocrine Therapy Medication Sales by Country (2019-2024) & (K Units)
 Table 27. North America Endocrine Therapy Medication Sales by Country (2025-2030) & (K Units)
 Table 28. North America Endocrine Therapy Medication Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Endocrine Therapy Medication Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Endocrine Therapy Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Endocrine Therapy Medication Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Endocrine Therapy Medication Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Endocrine Therapy Medication Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Endocrine Therapy Medication Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Endocrine Therapy Medication Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Endocrine Therapy Medication Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Endocrine Therapy Medication Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Endocrine Therapy Medication Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Endocrine Therapy Medication Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Endocrine Therapy Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Endocrine Therapy Medication Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Endocrine Therapy Medication Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Endocrine Therapy Medication Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Endocrine Therapy Medication Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Endocrine Therapy Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Endocrine Therapy Medication Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Endocrine Therapy Medication Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Endocrine Therapy Medication Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Endocrine Therapy Medication Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Endocrine Therapy Medication Sales (K Units) by Type (2019-2024)
 Table 51. Global Endocrine Therapy Medication Sales (K Units) by Type (2025-2030)
 Table 52. Global Endocrine Therapy Medication Sales Market Share by Type (2019-2024)
 Table 53. Global Endocrine Therapy Medication Sales Market Share by Type (2025-2030)
 Table 54. Global Endocrine Therapy Medication Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Endocrine Therapy Medication Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Endocrine Therapy Medication Revenue Market Share by Type (2019-2024)
 Table 57. Global Endocrine Therapy Medication Revenue Market Share by Type (2025-2030)
 Table 58. Global Endocrine Therapy Medication Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Endocrine Therapy Medication Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Endocrine Therapy Medication Sales (K Units) by Application (2019-2024)
 Table 61. Global Endocrine Therapy Medication Sales (K Units) by Application (2025-2030)
 Table 62. Global Endocrine Therapy Medication Sales Market Share by Application (2019-2024)
 Table 63. Global Endocrine Therapy Medication Sales Market Share by Application (2025-2030)
 Table 64. Global Endocrine Therapy Medication Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Endocrine Therapy Medication Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Endocrine Therapy Medication Revenue Market Share by Application (2019-2024)
 Table 67. Global Endocrine Therapy Medication Revenue Market Share by Application (2025-2030)
 Table 68. Global Endocrine Therapy Medication Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Endocrine Therapy Medication Price (US$/Unit) by Application (2025-2030)
 Table 70. Maanshan Fengyuan Pharmaceutical Co., Ltd. Company Information
 Table 71. Maanshan Fengyuan Pharmaceutical Co., Ltd. Description and Business Overview
 Table 72. Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 74. Maanshan Fengyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 75. Shanghai Lizhu Pharmaceutical Co., Ltd. Company Information
 Table 76. Shanghai Lizhu Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 79. Shanghai Lizhu Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Zhongpeptide Biochemical Co., Ltd. Company Information
 Table 81. Zhongpeptide Biochemical Co., Ltd. Description and Business Overview
 Table 82. Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Product
 Table 84. Zhongpeptide Biochemical Co., Ltd. Recent Developments/Updates
 Table 85. Beijing Bornte Pharmaceutical Co., Ltd. Company Information
 Table 86. Beijing Bornte Pharmaceutical Co., Ltd. Description and Business Overview
 Table 87. Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 89. Beijing Bornte Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 90. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information
 Table 91. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Description and Business Overview
 Table 92. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 94. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 95. Shenzhen Hanyu Pharmaceutical Co., Ltd. Company Information
 Table 96. Shenzhen Hanyu Pharmaceutical Co., Ltd. Description and Business Overview
 Table 97. Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 99. Shenzhen Hanyu Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 100. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
 Table 101. Chongqing Laimi Pharmaceutical Co., Ltd. Description and Business Overview
 Table 102. Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 104. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 105. Changchun Jinsai Pharmaceutical Co., Ltd. Company Information
 Table 106. Changchun Jinsai Pharmaceutical Co., Ltd. Description and Business Overview
 Table 107. Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 109. Changchun Jinsai Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 110. Dandong Yichuang Pharmaceutical Co., Ltd. Company Information
 Table 111. Dandong Yichuang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 112. Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 114. Dandong Yichuang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 115. Good Doctor Pharmaceutical Group Co., Ltd. Company Information
 Table 116. Good Doctor Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 117. Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product
 Table 119. Good Doctor Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 120. Yangtze River Pharmaceutical Group Co., Ltd. Company Information
 Table 121. Yangtze River Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 122. Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product
 Table 124. Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 125. Zhejiang Haizhou Pharmaceutical Co., Ltd. Company Information
 Table 126. Zhejiang Haizhou Pharmaceutical Co., Ltd. Description and Business Overview
 Table 127. Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 129. Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Zhejiang Haizheng Pharmaceutical Co., Ltd. Company Information
 Table 131. Zhejiang Haizheng Pharmaceutical Co., Ltd. Description and Business Overview
 Table 132. Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 134. Zhejiang Haizheng Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 135. Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
 Table 136. Shanghai Zhaohui Pharmaceutical Co., Ltd. Description and Business Overview
 Table 137. Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 139. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 140. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
 Table 141. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Description and Business Overview
 Table 142. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 144. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 145. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Company Information
 Table 146. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Description and Business Overview
 Table 147. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 149. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 150. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information
 Table 151. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 152. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product
 Table 154. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 155. Eli Lilly and Company Company Information
 Table 156. Eli Lilly and Company Description and Business Overview
 Table 157. Eli Lilly and Company Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 158. Eli Lilly and Company Endocrine Therapy Medication Product
 Table 159. Eli Lilly and Company Recent Developments/Updates
 Table 160. Pfizer Company Information
 Table 161. Pfizer Description and Business Overview
 Table 162. Pfizer Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 163. Pfizer Endocrine Therapy Medication Product
 Table 164. Pfizer Recent Developments/Updates
 Table 165. Teva Company Information
 Table 166. Teva Description and Business Overview
 Table 167. Teva Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 168. Teva Endocrine Therapy Medication Product
 Table 169. Teva Recent Developments/Updates
 Table 170. AstraZeneca Company Information
 Table 171. AstraZeneca Description and Business Overview
 Table 172. AstraZeneca Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 173. AstraZeneca Endocrine Therapy Medication Product
 Table 174. AstraZeneca Recent Developments/Updates
 Table 175. Janssen Biotech Company Information
 Table 176. Janssen Biotech Description and Business Overview
 Table 177. Janssen Biotech Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 178. Janssen Biotech Endocrine Therapy Medication Product
 Table 179. Janssen Biotech Recent Developments/Updates
 Table 180. Dr. Reddy's Company Information
 Table 181. Dr. Reddy's Description and Business Overview
 Table 182. Dr. Reddy's Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 183. Dr. Reddy's Endocrine Therapy Medication Product
 Table 184. Dr. Reddy's Recent Developments/Updates
 Table 185. Cougar Biotechnology, Inc. Company Information
 Table 186. Cougar Biotechnology, Inc. Description and Business Overview
 Table 187. Cougar Biotechnology, Inc. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 188. Cougar Biotechnology, Inc. Endocrine Therapy Medication Product
 Table 189. Cougar Biotechnology, Inc. Recent Developments/Updates
 Table 190. Key Raw Materials Lists
 Table 191. Raw Materials Key Suppliers Lists
 Table 192. Endocrine Therapy Medication Distributors List
 Table 193. Endocrine Therapy Medication Customers List
 Table 194. Endocrine Therapy Medication Market Trends
 Table 195. Endocrine Therapy Medication Market Drivers
 Table 196. Endocrine Therapy Medication Market Challenges
 Table 197. Endocrine Therapy Medication Market Restraints
 Table 198. Research Programs/Design for This Report
 Table 199. Key Data Information from Secondary Sources
 Table 200. Key Data Information from Primary Sources
 Table 201. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Endocrine Therapy Medication
 Figure 2. Global Endocrine Therapy Medication Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Endocrine Therapy Medication Market Share by Type: 2023 & 2030
 Figure 4. Hormones and Related Drugs Product Picture
 Figure 5. Hormone Antagonists and Related Drugs Product Picture
 Figure 6. Global Endocrine Therapy Medication Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Endocrine Therapy Medication Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Endocrine Therapy Medication Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Endocrine Therapy Medication Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Endocrine Therapy Medication Sales (2019-2030) & (K Units)
 Figure 14. Global Endocrine Therapy Medication Average Price (US$/Unit) & (2019-2030)
 Figure 15. Endocrine Therapy Medication Report Years Considered
 Figure 16. Endocrine Therapy Medication Sales Share by Manufacturers in 2023
 Figure 17. Global Endocrine Therapy Medication Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Endocrine Therapy Medication Players: Market Share by Revenue in Endocrine Therapy Medication in 2023
 Figure 19. Endocrine Therapy Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Endocrine Therapy Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Endocrine Therapy Medication Sales Market Share by Country (2019-2030)
 Figure 22. North America Endocrine Therapy Medication Revenue Market Share by Country (2019-2030)
 Figure 23. United States Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Endocrine Therapy Medication Sales Market Share by Country (2019-2030)
 Figure 26. Europe Endocrine Therapy Medication Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Endocrine Therapy Medication Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Endocrine Therapy Medication Revenue Market Share by Region (2019-2030)
 Figure 34. China Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Endocrine Therapy Medication Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Endocrine Therapy Medication Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Endocrine Therapy Medication Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Endocrine Therapy Medication Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Endocrine Therapy Medication by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Endocrine Therapy Medication by Type (2019-2030)
 Figure 53. Global Endocrine Therapy Medication Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Endocrine Therapy Medication by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Endocrine Therapy Medication by Application (2019-2030)
 Figure 56. Global Endocrine Therapy Medication Price (US$/Unit) by Application (2019-2030)
 Figure 57. Endocrine Therapy Medication Value Chain
 Figure 58. Endocrine Therapy Medication Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network